⌘K

Login Start Free

Home/Filings/4/0001213900-17-002644

4//SEC Filing

ORAMED PHARMACEUTICALS INC. 4

Accession 0001213900-17-002644

$ORMPCIK 0001176309operating

View on SEC.gov Company Profile

Filed

Mar 20, 8:00 PM ET

Accepted

Mar 21, 12:09 PM ET

Size

5.5 KB

Accession

0001213900-17-002644

Insider Transaction Report

Form 4

Period: 2017-03-20

ORAMED PHARMACEUTICALS INC.ORMP

Law Ronald Edward

Chief Strategy Officer

Transactions

Award
Stock Option (right to buy)
2017-03-20+37,152→ 37,152 total
Exercise: $6.00Exp: 2027-03-20→ Common Stock (37,152 underlying)

Footnotes (1)

[F1]The Stock Option shall vest in 24 consecutive equal monthly installments commencing March 31, 2017.

Documents

1 file

4
f4032017law_oramedpharma.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001176309

Filing Metadata

Form type: 4
Filed: Mar 20, 8:00 PM ET
Accepted: Mar 21, 12:09 PM ET
Size: 5.5 KB

View on SEC.gov